Joohee Sul

2.4k total citations · 1 hit paper
26 papers, 1.7k citations indexed

About

Joohee Sul is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joohee Sul has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Joohee Sul's work include Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (12 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Joohee Sul is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (12 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Joohee Sul collaborates with scholars based in United States, Netherlands and Switzerland. Joohee Sul's co-authors include Fábio M. Iwamoto, Teri Kreisl, Howard A. Fine, Patricia Keegan, Gideon M. Blumenthal, Kun He, Richard Pazdur, Xiaoping Jiang, Joanna H. Shih and Lisa M. DeAngelis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Joohee Sul

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1

2016 285 citations Joohee Sul, Patricia Keegan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joohee Sul United States	17	912	565	491	365	328	26	1.7k
R. Rampling United Kingdom	19	1.3k 1.5×	681 1.2×	500 1.0×	565 1.5×	452 1.4×	30	2.1k
Laëtitia Padovani France	23	761 0.8×	404 0.7×	463 0.9×	564 1.5×	282 0.9×	86	1.7k
Beatrice Malmer Sweden	25	831 0.9×	424 0.8×	460 0.9×	713 2.0×	375 1.1×	42	2.1k
Matteo Simonelli Italy	27	818 0.9×	823 1.5×	691 1.4×	439 1.2×	265 0.8×	129	2.5k
Dana Cernea Romania	8	1.4k 1.5×	557 1.0×	462 0.9×	595 1.6×	486 1.5×	16	2.0k
Sridhar Epari India	23	783 0.9×	360 0.6×	288 0.6×	599 1.6×	293 0.9×	198	1.9k
Dorothee Gramatzki Switzerland	19	843 0.9×	345 0.6×	335 0.7×	444 1.2×	343 1.0×	59	1.4k
Miguel Gil‐Gil Spain	23	600 0.7×	619 1.1×	814 1.7×	322 0.9×	396 1.2×	101	1.7k
Benoît Lhermitte France	18	1.1k 1.2×	702 1.2×	710 1.4×	821 2.2×	647 2.0×	77	2.5k
Jean‐Sébastien Guillamo France	17	993 1.1×	570 1.0×	196 0.4×	320 0.9×	342 1.0×	28	1.5k

Countries citing papers authored by Joohee Sul

Since Specialization

Citations

This map shows the geographic impact of Joohee Sul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joohee Sul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joohee Sul more than expected).

Fields of papers citing papers by Joohee Sul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joohee Sul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joohee Sul. The network helps show where Joohee Sul may publish in the future.

Co-authorship network of co-authors of Joohee Sul

This figure shows the co-authorship network connecting the top 25 collaborators of Joohee Sul. A scholar is included among the top collaborators of Joohee Sul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joohee Sul. Joohee Sul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kluetz, Paul G., Patricia Keegan, George D. Demetri, et al.. (2020). FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs. Clinical Cancer Research. 27(4). 916–921. 8 indexed citations

Armstrong, Terri S., Linda Dirven, David Arons, et al.. (2020). Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. The Lancet Oncology. 21(2). e97–e103. 50 indexed citations

Lin, Nancy U., Tatiana M. Prowell, Antoinette R. Tan, et al.. (2017). Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group. Journal of Clinical Oncology. 35(33). 3760–3773. 74 indexed citations

Odia, Yazmín, Joohee Sul, Joanna H. Shih, et al.. (2016). A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma. CNS Oncology. 5(2). 59–67. 24 indexed citations

Sul, Joohee, Paul G. Kluetz, Elektra J. Papadopoulos, & Patricia Keegan. (2015). Clinical outcome assessments in neuro-oncology: a regulatory perspective. Neuro-Oncology Practice. 3(1). 4–9. 10 indexed citations

Levin, Victor A., Peter J. Tonge, James M. Gallo, et al.. (2015). CNS Anticancer Drug Discovery and Development Conference White Paper. Neuro-Oncology. 17(suppl 6). vi1–vi26. 34 indexed citations

Odia, Yazmín, Fábio M. Iwamoto, Tyler J. Fraum, et al.. (2015). A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas. Journal of Neuro-Oncology. 127(1). 127–135. 35 indexed citations

Ho, Jennifer, John Ondos, Holly Ning, et al.. (2013). Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience. PLoS ONE. 8(8). e70745–e70745. 12 indexed citations

Kreisl, Teri, Joohee Sul, Carlos A. Salgado, et al.. (2012). Continuous daily sunitinib for recurrent glioblastoma. Journal of Neuro-Oncology. 111(1). 41–48. 79 indexed citations

10.

McNeill, K., et al.. (2012). A phase I/II trial of vandetanib for patients with recurrent malignant glioma. Neuro-Oncology. 14(12). 1519–1526. 65 indexed citations

11.

Fraum, Tyler J., Teri Kreisl, Joohee Sul, Howard A. Fine, & Fábio M. Iwamoto. (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. Journal of Neuro-Oncology. 105(2). 281–289. 62 indexed citations

12.

Kreisl, Teri, Wei Zhang, Yazmín Odia, et al.. (2011). A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro-Oncology. 13(10). 1143–1150. 90 indexed citations

13.

Milano, Michael T., Paul Okunieff, Nimish Mohile, et al.. (2010). Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 78(4). 1147–1155. 121 indexed citations

14.

Sul, Joohee & Howard A. Fine. (2010). Malignant Gliomas: New Translational Therapies. Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine. 77(6). 655–666. 15 indexed citations

15.

Kreisl, Teri, et al.. (2010). Phase I/II study of vandetanib for patients with recurrent malignant gliomas.. Journal of Clinical Oncology. 28(15_suppl). 2083–2083. 1 indexed citations

16.

Clarke, Jennifer, Fábio M. Iwamoto, Joohee Sul, et al.. (2009). Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma. Journal of Clinical Oncology. 27(23). 3861–3867. 128 indexed citations

17.

Milano, Michael T., Mahlon D. Johnson, Joohee Sul, et al.. (2009). Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. Journal of Neuro-Oncology. 98(1). 83–92. 97 indexed citations

18.

Sul, Joohee & Jerome B. Posner. (2007). Brain Metastases: Epidemiology and Pathophysiology. Cancer treatment and research. 136. 1–21. 47 indexed citations

19.

Sul, Joohee & Lisa M. DeAngelis. (2006). Neurologic Complications of Cancer Chemotherapy. Seminars in Oncology. 33(3). 324–332. 40 indexed citations

20.

Sul, Joohee. (2005). Cancer Neurology in Clinical Practice. Neurology. 64(9). 1668–1668. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact